Patent · US Active

Compound for treatment of allergy and asthma

USRE42324E1 · kind E1 · reissue

1Cited by

4References

15Claims

0Family size

Assignee

PHADIA AB · SE

Inventors

Sylvia Laffer · Wien, AT
Erik Hogbom · Uppsala, SE
Kenneth H. Roux · Tallahassee, US
Jonas Adriansson · Uppsala, SE
Wolfgang Sperr · Wien, AT
Peter Valent · Wien, AT
Dietrich Kraft · Wien, AT
Hans Grönlund · Lidingö, SE
Rudolf Valenta · Theresienfeld, AT

Key dates

Filing date	Apr 9, 2010
Grant date	May 3, 2011
Priority date	—
Expiry date	Apr 9, 2030

Classification

Technology area (CPC —)General

Abstract

The present invention relates to a novel drug candidate having a potential for universal therapy of allergy and asthma.The invention provides a Fab (antibody fragment), having the following characteristics:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.